AU650946B2 - Analgesic compositions - Google Patents

Analgesic compositions

Info

Publication number
AU650946B2
AU650946B2 AU10730/92A AU1073092A AU650946B2 AU 650946 B2 AU650946 B2 AU 650946B2 AU 10730/92 A AU10730/92 A AU 10730/92A AU 1073092 A AU1073092 A AU 1073092A AU 650946 B2 AU650946 B2 AU 650946B2
Authority
AU
Australia
Prior art keywords
ibuprofen
weight
oil
composition
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU10730/92A
Other languages
English (en)
Other versions
AU1073092A (en
Inventor
Gary Robert Agisim
Robert George Blank
Gloria Yoshiko Chen
Dhiraj Shantilal Mody
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU1073092A publication Critical patent/AU1073092A/en
Application granted granted Critical
Publication of AU650946B2 publication Critical patent/AU650946B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU10730/92A 1991-02-11 1992-02-06 Analgesic compositions Ceased AU650946B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US65411791A 1991-02-11 1991-02-11
US654117 1991-02-11
US74101191A 1991-08-06 1991-08-06
US814995 1992-01-08
US07/814,995 US5210099A (en) 1991-02-11 1992-01-08 Analgesic compositions
US741011 1996-10-31

Publications (2)

Publication Number Publication Date
AU1073092A AU1073092A (en) 1992-08-13
AU650946B2 true AU650946B2 (en) 1994-07-07

Family

ID=27417914

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10730/92A Ceased AU650946B2 (en) 1991-02-11 1992-02-06 Analgesic compositions

Country Status (18)

Country Link
US (1) US5210099A (enExample)
EP (1) EP0499399B1 (enExample)
JP (1) JPH0558884A (enExample)
KR (1) KR920016087A (enExample)
AT (1) ATE147624T1 (enExample)
AU (1) AU650946B2 (enExample)
CA (1) CA2060833C (enExample)
DE (1) DE69216650T2 (enExample)
DK (1) DK0499399T3 (enExample)
ES (1) ES2096712T3 (enExample)
FI (1) FI100856B (enExample)
GR (1) GR3022886T3 (enExample)
IE (1) IE920245A1 (enExample)
MX (1) MX9200554A (enExample)
NO (1) NO179273C (enExample)
NZ (1) NZ241547A (enExample)
TW (1) TW225987B (enExample)
UY (1) UY23373A1 (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
DE4405641C2 (de) * 1994-02-22 1997-04-30 Roemmers Sa Pharmazeutische Zusammensetzung, enthaltend 2-(4-Methoxyphenoxy)-3-pyridinamin
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
ES2118033B1 (es) * 1996-02-16 1999-07-01 Bial Ind Farmaceutica S A Formulacion farmaceutica antiinflamatoria.
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US6083996A (en) * 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
WO1999026571A1 (en) * 1997-11-25 1999-06-03 Theratech, Inc. Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
WO2003028702A1 (en) * 2001-10-04 2003-04-10 Macrochem Corporation Ibuprofen salt emulsifiers and cream formulations containing same
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
EP1732577B1 (en) * 2004-02-23 2013-04-10 Strategic Science & Technologies, LLC Topical delivery of l-arginine to improve body and skin appearance
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
JP2007532697A (ja) * 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
TW200613004A (en) * 2004-08-31 2006-05-01 Aspion Co Ltd External preparation of solid/oil type
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
US20070098660A1 (en) * 2005-10-27 2007-05-03 Jim Taneri Methods and compositions for epilation
US20080095831A1 (en) * 2006-08-10 2008-04-24 Mc Graw Thomas L Topical formulation of multilamellar vesicles composition for percutaneous absorption of pharmaceutically active agent
KR20110017365A (ko) * 2008-05-30 2011-02-21 페어필드 클리니컬 트라이얼즈 엘엘씨 피부 염증 및 변색을 위한 방법 및 조성물
BRPI0918142A2 (pt) 2008-09-10 2015-12-01 Biochemics Inc composição farmaclógica tópica, seu método de preparação, bem como uso da forma de ácido livre de ácido 2-(4-isobutifilfenil)prpiônico
MX349176B (es) 2008-09-22 2017-07-14 Biochemics Inc Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo.
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
US20100099775A1 (en) * 2008-10-17 2010-04-22 Alpharx Inc. Method for ameliorating of post-anesthetic recovery
EP2445493A1 (en) 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topical composition containing naproxen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
CN102481275B (zh) 2009-06-24 2014-07-23 战略科学技术有限公司 含有布洛芬的表面组合物
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
CN103442723A (zh) 2010-12-29 2013-12-11 战略科学与技术有限责任公司 治疗变态反应和其它适应症的系统和方法
EP2658551B1 (en) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Treatment of erectile dysfunction and other indications
US9452135B2 (en) 2012-03-20 2016-09-27 Particle Dynamics International, Llc Gelling agent-based dosage form
JP6121796B2 (ja) * 2012-05-23 2017-04-26 キユーピー株式会社 脂肪乳剤および医薬品組成物中の非ステロイド性抗炎症薬の含有量を高める方法
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
EP3268085A4 (en) 2015-03-13 2018-10-31 The Board of Trustees of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
WO2019112848A1 (en) 2017-12-04 2019-06-13 Johnson & Johnson Consumer Inc. Topical emulsion composition containing nonsteroidal anti-inflammatory drug

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4385049A (en) * 1981-05-12 1983-05-24 K-V Pharmaceutical Company Stable high internal phase ratio topical emulsions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2742396A (en) * 1952-08-13 1956-04-17 Purdue Research Foundation Ointment base
CA727589A (en) * 1962-12-27 1966-02-08 Braun Ernest Depilatory composition
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4385049A (en) * 1981-05-12 1983-05-24 K-V Pharmaceutical Company Stable high internal phase ratio topical emulsions

Also Published As

Publication number Publication date
FI920523L (fi) 1992-08-12
MX9200554A (es) 1992-08-01
IE920245A1 (en) 1992-08-12
EP0499399B1 (en) 1997-01-15
NO179273C (no) 1996-09-11
NO920527L (no) 1992-08-12
NZ241547A (en) 1993-02-25
DK0499399T3 (da) 1997-02-03
ES2096712T3 (es) 1997-03-16
TW225987B (enExample) 1994-07-01
DE69216650D1 (de) 1997-02-27
JPH0558884A (ja) 1993-03-09
EP0499399A1 (en) 1992-08-19
AU1073092A (en) 1992-08-13
US5210099A (en) 1993-05-11
FI100856B (fi) 1998-03-13
KR920016087A (ko) 1992-09-24
CA2060833A1 (en) 1992-08-12
UY23373A1 (es) 1992-07-23
NO179273B (no) 1996-06-03
DE69216650T2 (de) 1997-05-07
GR3022886T3 (en) 1997-06-30
FI920523A0 (fi) 1992-02-07
ATE147624T1 (de) 1997-02-15
NO920527D0 (no) 1992-02-10
CA2060833C (en) 1997-12-30

Similar Documents

Publication Publication Date Title
AU1073092A (en) Analgesic compositions
AU4276896A (en) Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
DE3176125D1 (en) 1-carboxyalkanoylindolin-2-carboxylic acids and derivatives thereof, processes for their preparation, and pharmaceutical compositions containing these compounds
CA2019516A1 (en) Method of Oil Well Corrosion Inhibition Via Emulsions and Emulsions Therefor
EP0391124A3 (en) Cosmetic composition of double emulsion type
IL105511A (en) 2,4-dioxoimidazolidine derivatives their preparation and pharmaceutical compositions containing them
MY113936A (en) Solutions and their preparation
IL102759A0 (en) Hydantoin derivatives,their preparation and pharmaceutical compositions containing them
OA05820A (fr) Concentré pour la préparation de microémulsions d'huile et d'eau de forte salinité.
AU2968089A (en) Emulsion compositions including amphipathic emulsifying agents
FR2706298B1 (fr) Composition cosmétique ou dermatologique sous forme d'une émulsion huile-dans-l'eau stable contenant au moins une huile végétale constituée d'au moins 40% de triglycérides d'acide linoléique.
FI113739B (fi) Öljy vedessä -emulsioita mikrobisidien (biosidien) korvaajina vettä sisältävissä systeemeissä
DE3478029D1 (en) Biopolymer compositions and process for their preparation
ATE139435T1 (de) Kosmetische und dermatologische zubereitungen
GB2061315B (en) Micellar compositions and their use in breaking petroleum emulsions
GR3023677T3 (en) Neutral auto-gloss emulsion for the maintenance of floors (iii).
GB2343189B (en) Skin cleansing composition
CA2150213A1 (en) Aqueous Composition Useful in Ore Flotation Containing Aliphatic Amine, Extender Oil, and Emulsifier
TW343159B (en) Process for production of emulsion
DE29814159U1 (de) Minerot-Oetinger, Mineralmischung (Elektrolytmischung)
CA2189863A1 (en) Mucoadhesive emulsions containing cyclodextrin
MY109166A (en) Fertilizer composition comprising dispersions or solutions of nutrient compounds